Turkey Pharmaceutical Export

Turkey Pharmaceutical Export: Sector Overview

Turkey pharmaceutical export has shown significant growth in recent years. With its strategic location, developed manufacturing infrastructure and competitive prices, Turkey has become an important player in the global pharmaceutical market.

Turkey's Advantages in Pharmaceutical Export

• Strategic Location: Bridge between Europe, Asia and Africa
• Manufacturing Capacity: Modern GMP certified facilities
• Competitive Prices: Cost-effective production
• Quality Standards: EU harmonized regulations
• Skilled Workforce: Experienced pharmaceutical professionals

Main Export Markets

Middle East and North Africa

Iraq, Saudi Arabia, UAE, Egypt and Libya are major markets for Turkish pharmaceutical exports.

European Union

Germany, Netherlands, UK and France represent high-value markets with strict quality requirements.

Central Asia and CIS

Kazakhstan, Uzbekistan, Azerbaijan and Turkmenistan are growing markets with cultural ties.

Export Statistics and Growth

Turkey's pharmaceutical export has been growing at an average rate of 15% annually. The sector aims to reach $3 billion in exports by 2030.

Future Outlook

With increasing investments in R&D and biotechnology, Turkey pharmaceutical export is expected to continue its growth trajectory. Government incentives and free trade agreements further support this growth.

Contact xPharma to learn more about pharmaceutical export opportunities from Turkey.